Deutsche Bank Ag\ Cerevel Therapeutics Holdings, Inc. Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.96 - $42.75 $22.1 Million - $24.2 Million	-566,542 Reduced 98.97%	5,925 $242,000
Q1 2024 May 15, 2024	BUY	$40.88 - $43.27 $8.59 Million - $9.09 Million	210,053 Added 57.96%	572,467 $24.2 Million
Q4 2023 Feb 14, 2024	BUY	$20.27 - $42.44 $6.66 Million - $13.9 Million	328,487 Added 968.22%	362,414 $15.4 Million
Q3 2023 Nov 09, 2023	BUY	$20.26 - $31.91 $93,175 - $146,754	4,599 Added 15.68%	33,927 $740,000
Q2 2023 Aug 14, 2023	SELL	$23.9 - $35.38 $286,919 - $424,736	-12,005 Reduced 29.04%	29,328 $932,000
Q1 2023 May 15, 2023	BUY	$22.82 - $35.32 $263,228 - $407,416	11,535 Added 38.71%	41,333 $1.01 Million
Q4 2022 Feb 13, 2023	BUY	$25.35 - $31.96 $124,189 - $156,572	4,899 Added 19.68%	29,798 $939,000
Q3 2022 Nov 14, 2022	SELL	$25.5 - $41.42 $185,844 - $301,868	-7,288 Reduced 22.64%	24,899 $704,000
Q2 2022 Aug 11, 2022	BUY	$20.62 - $37.15 $119,719 - $215,692	5,806 Added 22.01%	32,187 $850,000
Q1 2022 May 13, 2022	SELL	$23.5 - $35.38 $46,130 - $69,450	-1,963 Reduced 6.93%	26,381 $924,000
Q4 2021 Feb 11, 2022	BUY	$29.21 - $44.64 $54,768 - $83,700	1,875 Added 7.08%	28,344 $919,000
Q3 2021 Nov 04, 2021	BUY	$21.26 - $38.85 $85,486 - $156,215	4,021 Added 17.91%	26,469 $781,000
Q2 2021 Aug 11, 2021	BUY	$12.56 - $29.69 $281,946 - $666,481	22,448 New	22,448 $575,000

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.